Production of fatty alcohols from engineered microorganisms
US-9714437-B2 · Jul 25, 2017 · US
US11015180B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11015180-B2 |
| Application number | US-201816218003-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2018 |
| Priority date | Dec 13, 2017 |
| Publication date | May 25, 2021 |
| Grant date | May 25, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides engineered carboxyesterase enzymes having improved properties as compared to a naturally occurring wild-type carboxyesterase enzymes, as well as polynucleotides encoding the engineered carboxyesterase enzymes, host cells capable of expressing the engineered carboxyesterase enzymes, and methods of using the engineered carboxyesterase enzymes in amidation reactions.
Opening claim text (preview).
The invention claimed is: 1. An engineered carboxyesterase comprising a polypeptide sequence having at least 80% sequence identity to SEQ ID NO: 2, wherein said engineered carboxyesterase comprises a substitution in said polypeptide sequence at position 282, wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2, and wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase of SEQ ID NO:2. 2. The engineered carboxyesterase of claim 1 , wherein said polypeptide sequence further comprises substitutions at positions selected from: 39, 39/323, 62, 62/117, 63, 64, 65, 66, 68, 69, 70, 71, 71/263, 77, 77/184, 103, 103/147, 104, 104/429, 105, 107, 107/185, 108, 109, 109/117, 110, 111, 113, 114, 115, 117, 118, 118/269, 118/349, 119, 126, 147, 153, 153/215, 164, 164/271, 174, 183, 184, 184/249, 185, 186, 187, 188, 190, 209, 210, 211, 212, 213, 213/271, 213/345, 214, 215, 215/271, 216, 217, 217/231, 224, 224/268/372, 231, 249, 249/284, 263, 268, 269, 270, 270/470, 271, 271/416, 276, 277, 278, 279, 280, 281, 281/374, 283, 283/429, 284, 284/438, 285, 286, 311, 317, 320, 320/323, 320/323/372, 320/372/376, 320/376/377, 321, 323, 324, 345, 349, 372, 372/376, 373, 374, 376, 377, 405, 416, 420, 427, 428, 429, 438, and 470, wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 2. 3. The engineered carboxyesterase of claim 1 , wherein said amino acid at position 282 is a polar amino acid. 4. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase comprises an amino acid substitution selected from: X282Q, X282S, and X282T, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 2. 5. The engineered carboxyesterase of claim 1 , wherein said polypeptide sequence is selected from: SEQ ID NOs: 4, 6, 8, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132 and 134. 6. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase comprises improved amidation activity as compared to the wild-type T. fusca carboxyesterase of SEQ ID NO:2. 7. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase on a substrate comprising isobutylamine. 8. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase on the substrate set comprising isobutylamine and ethyl benzoate. 9. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase in producing a product comprising N-isobutyl-benzamide. 10. The engineered carboxyesterase of claim 1 , further comprising at least one substitution selected from: L343V, L372L, L320W/G, L214R, L271Y and L65G, wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2. 11. The engineered carboxyesterase of claim 1 , further comprising at least one substitution selected from: L268A, L63A/R, L189Q/I/E, L214R, L381L, and L69W, wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2. 12. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase is purified. 13. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase is immobilized on a solid support. 14. A composition comprising at least one engineered carboxyesterase of claim 1 .
Carboxylic ester hydrolases {(3.1.1)} · CPC title
Carboxylesterase (3.1.1.1) · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Biofuels, e.g. bio-diesel · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.